Change of Corporate Broker

AI SummaryClose X

Cizzle Biotechnology Holdings PLC has appointed Zeus Capital Limited as its sole Corporate Broker, effective immediately. This change in brokerage is a significant development for the company, which is focused on developing a non-invasive blood test for early lung cancer detection using the CIZ1B biomarker. The company has recently entered into commercial royalty-bearing arrangements and collaborations to advance its proprietary technology.

Disclaimer*

UK 100

Latest directors dealings